Drug Trial Radar · NCT01141023
Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Last checked: Nov 20, 2026Latest source record: Nov 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
952
Actual
Start
Jun 2010
Primary completion
Jun 30, 2020
Study completion Jun 30, 2020
Sponsor
- Lead sponsor
- Ken Marek, MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Institute for Neurodegenerative Disorders
- First posted
- Jun 10, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a observational, multi-center study to assess progression of clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients compared to healthy controls (HC) and in PD patient subtypes. The primary objective of this study is to identify clinical, imaging and biologic markers of PD progression for use in clinical trials of disease-modifying therapies.
Conditions
- Parkinson Disease
Interventions
DaTscanDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Rates of ChangeTime frame: Baseline to 156 months
Locations
34 sites in 11 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Banner Research Institute
Sun City, Arizona
University of California San Diego
La Jolla, California
University of California, San Francisco
San Francisco, California
The Parkinson's Institute
Sunnyvale, California
Institute For Neurodegenerative Disorders
New Haven, Connecticut
Parkinson's Disease& Movement Disorder Center of Boca Raton
Boca Raton, Florida
University of South Florida
Tampa, Florida
Emory University School of Medicine
Atlanta, Georgia
Northwestern University
Chicago, Illinois
John Hopkins University
Baltimore, Maryland
Boston University
Boston, Massachusetts
Beth Israel Medical Center
New York, New York
Columbia University Medical Center
New York, New York
University of Rochester
Rochester, New York
University of Cincinnati/Cincinnati Children's Hospital
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
Oregon Health &Science University
Portland, Oregon
University of Pennsylvania
Philadelphia, Pennsylvania
Baylor College of Medicine
Houston, Texas
Univ of Washington and VA Puget Sound Health Care System
Seattle, Washington
Macquarie University
Sydney, Australia
Innsbruck Medical University
Innsbruck, Austria
Hospital Pitie-Salpetriere
Paris, France
Paracelsus-Elena Klinik
Kassel, Germany
University of Tuebingen
Tübingen, Germany
Foundation for Biomedical Research of the Academy of Athens
Athens, Greece
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Universita Federico II
Naples, Italy
University of Salerno
Salerno, Italy
St. Olavs Hospital
Trondheim, Norway
Hospital Clinic de Barcelona
Barcelona, Spain
Hospital Donostia
Donostia / San Sebastian, Spain
Imperial College London
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.